herb and mineral combination product
Dietary Supplementherb and mineral product containing cinnamon, turmeric and holy basil
NCT Number: NCT02146157
This is a multi-center, randomized, double-blind, placebo-controlled study in approximately 104 subjects (52 per group) to evaluate the effectiveness of an herb and mineral combination product on fasting serum glucose levels in subjects with impaired fasting glucose. The study consists of 5 visits: a Screening visit, followed by a Baseline visit (at which eligible subjects will be randomized to product to consume throughout the 12-week supplementation period), followed by Supplementation period visits at 3, 6 and 12 weeks after baseline.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Radiant Research, Chicago, Illinois, United States
The target population of this clinical trial is otherwise healthy, pre-diabetic adults who present with impaired fasting glucose.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
herb and mineral product containing cinnamon, turmeric and holy basil
Placebo of herb and mineral product containing cinnamon, turmeric and holy basil
Time frame: Day 84
Fasting glucose will be measured on serum samples obtained at screening (to be used as baseline value) and at day 84
Time frame: Day 42
Fasting glucose will be measured on serum samples obtained at screening (to be used as baseline value) and at day 42
Time frame: Day 21
Fasting glucose will be measured on serum samples obtained at screening (to be used as baseline value) and at day 21
Time frame: Day 84
Glycosylated hemoglobin (HbA1c) will be measured on whole blood samples obtained at screening and at day 84.
Time frame: Day 84
Total cholesterol, high-density lipoprotein, low-density lipoprotein, very low-density lipoprotein, and triglycerides will be measured on serum samples obtained at screening and at day 84 using a standard lipid panel.
Time frame: Day 42
Total cholesterol, high-density lipoprotein, low-density lipoprotein, very low-density lipoprotein, and triglycerides will be measured on serum samples obtained at screening and at day 42 using a standard lipid panel.
Time frame: Day 21
Total cholesterol, high-density lipoprotein, low-density lipoprotein, very low-density lipoprotein, and triglycerides will be measured on serum samples obtained at screening and at day 21 using a standard lipid panel.
Time frame: Day 84
Body mass index
Time frame: Day 84
NewChapter, Inc.
Industry
A Randomized, Double-blind, Placebo-controlled Trial to Assess Efficacy and Tolerability of an Herb and Mineral Combination Product on Fasting Glucose in Adults at Risk for Developing Diabetes
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07618663
Diabetes Mellitus, Endocrine System Diseases
Lahore, Shaikhupura, Pakistan
View Trial DetailsNCT05351359
Diabetes Mellitus, Diabetes Mellitus, Type 2
Prague, Czechia
View Trial DetailsNCT07713394
Behavior, Body Weight
Erzurum, Turkey, Turkey (Türkiye)
View Trial DetailsNCT07710898
Diabete Mellitus, Diabetes Mellitus
Lahore, Pakistan
View Trial Details